Veterinary Imaging Market- Trends and Global Demand, Report and Forecast

 

Market Research Future published a Half-Cooked Research Report on “Global Veterinary Imaging Market Research Report - Forecast to 2023”– Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Global Veterinary Imaging Market  - Overview

The global veterinary imaging market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Veterinary deals with diagnosis and treatment of diseases in animals. Veterinary imaging devices are useful in diagnosis and treatment of diseases in animals. These devices also gives clear understanding of disease or injury that helps veterinarian for treatment of animal. Increasing awareness about animal healthcare and improvement of animal life are key factors for the growth of the market. Disease pattern in animals are continuously changing and becoming more challenging for veterinarians to diagnose these diseases. Veterinary imaging devices gives them in accurate diagnosis and further treatment. Increasing pet adoption is another major factor for the growth of the market. Increasing number of veterinarians, veterinary clinics and growing veterinary healthcare infrastructure are driving the growth for the market. Cattle are very important part of farming that have economic importance because they provides many products like milk, meat and leather. Farmers are becoming more aware about the health of their cattle which is good sign for the growth of the market. About 75% of veterinarians are working in private hospitals or pet clinics and these hospitals or clinics are spending money in advancement of technology to provide better facilities. Veterinary imaging devices manufacturers are spending money to develop innovative and usable product for the market. However there are some factors are inhibiting the growth of the market such as high cost of devices that small clinics cannot afford, lack of knowledge about new technology or products, availability of products, access to veterinary healthcare facilities, lack of skilled veterinary professionals etc.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2919    

Top Companies:

Atlantis Worldwide (US), Canon Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Fujifilm Holdings Corporation (Japan), GE Healthcare (US), Hitachi, Ltd (Japan), Medical Imaging / IMCO, Inc. (US), Sectra (Sweden), Siemens AG (Germany), Toshiba Medical Systems Corporation (Japan) are some of the prominent players at the forefront of competition in the Global Veterinary Imaging Market and are profiled in MRFR Analysis. 

Global Veterinary Imaging Market  - Competitive Analysis

Characterized by the presence of several well-established and small players, the global market of veterinary imaging appears to be highly competitive and fragmented. Major market players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The Market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers. Therefore, key players ensure that their portfolio includes products both for treating sick animals and for preventing disease occurrence.

December, 2015 - Fujifilm and Anicom Holdings, Inc. entered into partnership and established joint venture for developing and providing cutting-edge veterinary technologies and services with focus on regenerative medicine. According to company reports, it had developed advanced veterinary medicine by combining Fujifilm's advanced production engineering and quality control technology nurtured in its photographic film business as well as diagnostic imaging technology, blood's chemical composition analysis technology and regenerative medical technology, with Anicom's veterinary hospital network, electronic medical record system and extensive animal treatment data. Moreover, the company had conducted science-based clinical research such as regenerative medicine including cell therapies.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Global Veterinary Imaging Market - Regional Analysis

Depending on geographic region, veterinary imaging market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America holds be the largest market for veterinary imaging due to increasing awareness about animal healthcare and increasing investment in healthcare domain. Moreover the European market is also growing and second largest market for Veterinary Imaging. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the Veterinary Imaging during the forecasted period. Whereas, The Middle East & Africa have the least market share. Additionally, factors such as lack of awareness, low healthcare expenditures will restrain the market during the corresponding period.

Report Details @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Theranostics Market Demand, Growth And Forecast MRFR

 Key Playersof the prominent players in the global theranostics market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Focus Diagnostics, Abbott Laboratories, Illumina, Inc., Agilent Technologies, Inc., QIAGEN, Myriad Genetics, Inc., Foundation Medicine, Inc., and AmeriPath, Inc.

 

Market Highlights

The global theranostics market size accounted for USD 7,968.4 million in 2018 and is projected to grow at a CAGR of 11.4% over the forecast period. Theranostics is a new field of medicine which combines therapeutics, nanoscience, and diagnostics based on specific targeted diagnostic tests. Theranostics is also called as theragnostics or companion diagnostics (CDx), or pharmacodiagnostics or personalized medical care, or personalized therapy, or personalized medicine technology.

 

Get Free Sample@ https://www.marketresearchfuture.com/sample_request/8057

 

Theranostics is a proposed diagnostic methodology for personalizing therapeutic intervention and the integration of imaging and therapy in a single system, enabling simultaneous therapy and follow-up of the treatment. Some of the market growth factors are increasing development of novel companion diagnostic tests, emerging use of theranostics, increasing partnerships and collaborations by major market players to develop innovative companion diagnostics, and rising burden of chronic diseases. In contrast, lack of proper defined regulations for theranostics tests and inadequate reimbursement facilities in most of the countries are anticipated to impede the market growth during the forecast period.

Molecular theranostics is a major field which includes small biochemical moieties and biomacromolecules. Theranostics is important for personalized as well as precision medicine that provides therapeutic outcome so that a physician can make a decision pertaining to the course of treatment for the patient.

 

Segmentation

The global theranostics market has been segmented into the therapeutic area, technology, end user, and region.

By therapeutic area, the market has been segmented into oncology, cardiovascular diseases, neurological disorders, immunological disorders, and others. The oncology segment is further categorized into breast cancer, colorectal cancer, lung cancer, cervical cancer, and others.

On the basis of technology, the market has been divided into polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), sequencing, and others. The sequencing segment is likely to register comparatively higher CAGR over the forecast period due to the increasing number of proof-of-concept case studies and research related to sequencing, particularly next-generation sequencing (NGS) technology.

Based on end user, the market has been classified into hospitals and clinics, diagnostic laboratories, and others.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/theranostics-market-8057

 

Regional Analysis

The global theranostics market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On a regional basis, the Americas would command the market throughout the forecast period attributed to the domicile of major market participants, increasing research and development activities, and growing adoption of theranostics in the US and Canada. For instance, in June 2018, Genome Canada launched a national initiative for clinical implementation of precision health that would ultimately impact the market growth in the near future.

Europe would follow Americas in terms of value over the forecast period due to flourishing pharmaceutical and medical device companies, increasing partnerships and collaborations between life science companies and medical diagnostics companies, and growing personalized medicine sector. Personalized medicine (PM) is an emerging approach to prevention, diagnosis, treatment, and care which is assisting in addressing the challenge of the aging of the population, rising prevalence of chronic diseases, and increasing healthcare costs.

The market in Asia-Pacific would register the fastest market growth over next seven years owing to booming medical tourism, swiftly developing healthcare infrastructure, and growing awareness in the developing countries, namely, India, China, Singapore, and Australia.

The Middle East & Africa has the least share of the global theranostics market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

 

Medical Oxygen Concentrators Market 2021 Analysis By Manufacturers, Latest Trends, Competitive Landscape And Strategies

Key Players

Few of the prominent players in the global medical oxygen concentrators market are Philips Healthcare, AirSep Corporation, Invacare Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart Industries, Inc., Nidek Medical Products, Inc., Inogen, Precision Medical, Inc., GCE Group, Besco Medical Limited, O2 Concepts, LLC, Teijin Limited, and OSI - Oxygen Solutions Inc.

Market Highlights

The Global Medical Oxygen Concentrators Market held a market value of USD 1,755.8 Million in 2018 and is Projected to Grow at a CAGR of 7.8% Over the Forecast Period. Oxygen concentrator, also called as oxygen generator is a medical device used to deliver oxygen to the patient. This device concentrates the oxygen from a gas supply by removing nitrogen to supply an oxygen-enriched product gas stream. Stationary oxygen concentrators are used as stationary sources to provide long-term oxygen therapy (LTOT) to patients at home. Oxygen concentrators provide supplementary oxygen for patients suffering from a chronic obstructive pulmonary disease (COPD) and in higher concentrations for pulmonary edema and severe chronic hypoxemia. In addition, this device is also used as an adjunct treatment for severe sleep apnea.

Factors driving the market growth are worldwide increasing the number of patients requiring long-term oxygen therapy, rising prevalence of the chronic obstructive pulmonary disease, sleep apnea, and asthma, growth in healthcare spending, growing demand for portable oxygen concentrators, and the presence of favorable government initiatives. For instance, according to the data published by World Bank, in 2010, world’s current healthcare expenditure (% of gross domestic product — GDP) was 9.57% that was soared to 10.02% in 2016. In contrast, the high cost of oxygen concentrators and huge loss of oxygen and energy when continuous flow technology is used are anticipated to impede the market growth over the forecast period. Price range varies from USD 1,100 to 4,000 (2,300 typical) for stationary units and 3,995 to 5,700 (5,000 typical) for portable units.

Portable oxygen concentrators are oxygen machines that draw in oxygen with the use of a battery, electricity or DC power. These oxygen concentrators offer advantages such as compact in size, lightweight, improved efficiency, cost economic price, and mobility that enables patients to travel hassle-free. Technological advancements in the portable oxygen concentrators include pressure swing adsorption (PSA), and membrane technology is helping in the swift adoption of portable medical oxygen concentrators.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876

Segmentation

The global medical oxygen concentrators market has been segmented into product, technology, indication, end user, and region.

By product, the market has been segmented into portable oxygen concentrators and stationary oxygen concentrators.

On the basis of technology, the market has been divided into the continuous flow and pulse dose.

Based on indication, the market has been categorized into chronic obstructive pulmonary disease, asthma, sleep apnea, and others.

By end user, the market has been classified into homecare, travel, hospitals and clinics, and others. Home oxygen concentrators facilitate convenience and make it easier and safer for the patient to complete their day-to-day activities, which is supporting the dominance of the homecare segment during the next six years.

Regional Analysis

The global medical oxygen concentrators market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of favorable government initiatives, reimbursement policies, and major market participants developed home healthcare care services and higher adoption of portable oxygen concentrators for homecare needs. Higher value contributors based in the US are Philips Healthcare, Invacare Corporation, AirSep Corporation, ResMed, and Precision Medical, Inc. In addition, government initiatives including the presence of the Federal Aviation Administration (FAA), which authorize the use of portable concentrators during air travel are promoting the dominance of the Americas.

Europe would follow the Americas in terms of revenue over the forecast period as the German government has been undertaking several initiatives to reduce pollution levels in the country and promote public health. In November 2018, the German government unveiled a 5-point plan to reduce plastic waste.

The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period. This is owing to rising prevalence of COPD and asthma, increasing spending on healthcare, growing awareness about state-of-the-art technologies in an oxygen concentrator, rising adoption of portable units, growth in disposable income, and changing diet pattern and lifestyle resulting in the development of diseases. As per data published in The Lancet journal, in 2016, the prevalence of COPD in India was 4·2% and the prevalence of asthma 2·9%. India has a higher prevalence of COPD than the global average, as well as more disability-adjusted life-years (DALYs) per person with COPD or asthma than the global average.

The Middle East & Africa has the least share of the global medical oxygen concentrators market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

 

Read More @ https://www.medgadget.com/2020/09/covid-19-impact-on-medical-oxygen-concentrators-market-size-competitive-outlook-future-trends-growth-insights-and-global-industry-analysis-by-2024.html

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Veterinary/Animal Vaccines Market Size, Share and Forecast to 2025

Veterinary/Animal Vaccines Market Information: By Type (Livestock Vaccines, Porcine Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Global Forecast till 2025

Overview:

 Be it as a means for food or as pets, animals have an age-old relationship with human beings. That is why the well-being of these animals become all the more necessary. Hence, veterinary vaccines are gaining traction across the Middle East & Africa (MEA). Veterinary vaccines ensure improved health and increased production of the livestock and reduce cost substantially. At the same time, it prohibits the transmission of diseases to other animals or human beings. Climate is playing a crucial role in triggering growth in number of the cases registered with animals getting affected by diseases. The second factor constantly influencing the market is the increase in spending on companion animals. This makes the owners seek assistance to apply veterinary vaccines to their animals to ensure their healthy life as well as of people around the animal. The region has a huge number of unvaccinated livestock which is becoming a concern as the dairy and meat sectors are also burgeoning. Hygiene has always been a problem with this region, and this can result in animals getting affected by diseases. And factors can have a knock-down effect on the MEA veterinary vaccines market and aid it to inflate with CAGR 7.1% during the forecast period (2013-2022) to reach USD 550.84 million, asserts Market Research Future (MRFR) in a detailed study.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2687

However, research and development in this sector can incur high investment which considering the end price of products may not seem beneficial. This can give the veterinary vaccines market an unwanted jolt. The market is also getting steep competition from its Chinese counterparts, and the animal industry is fairing poorly as Europe is gaining the upper hand in the region.

 

Segmentation:

 

The MEA market for veterinary vaccines can be segmented by technology, disease indication, composition, and animal type.

 

Technology-wise, the market can be segmented into attenuated, inactivated, toxoid, conjugate, subunit and recombinant DNA. Growing number of farms and animals as companions have given rise to attenuated segment which is currently dominating the market and the situation is expected to remain so in the foreseeable future.

 

Based on disease indication, the market includes foot & mouth disease, parvovirus, distemper, reproductive & respiratory syndrome and others.

 

Composition-based segmentation comprises mono vaccine and combination vaccines.

 

Based on animal type, the market consists poultry, bovine, porcine, companion and other. Poultry segment is accounted for the maximum market share followed by porcine. Meanwhile, companion section is witnessing significant market growth owing to the trend of adoption of pets.

 

Access Report @ https://www.marketresearchfuture.com/reports/mea-veterinary-vaccines-market-2687

 

Regional Analysis:

 

The MEA market for veterinary vaccines can be segmented into the UAE, Egypt, Saudi Arabia, Kuwait, Qatar, and Oman.

 

The UAE has the largest market for veterinary vaccines. The region has a well-formed healthcare setup that looks into the issue, and people with disposable income are also fond of pets which give the market considerable leverage in exploring significant possibilities.

 

Egypt is currently holding the second position. The local market here is driven by growing demand for meat and dairy product and to safeguard the source of such food and beverage, vaccines are necessary. Weather in the African continent is harsh but is ideal for diseases which spreads quite rapidly. Animals and human beings living in close proximity also increase chances of infection transmission which has to be taken into consideration for a better lifestyle.

 

Market Competition:

 

The market is getting some recognition from the concerned authorities as it can benefit from the associated industries significantly. Presence of several foreign companies in the region is also proving vital for the market.

 

Some of the key players in this market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck Animal Health, MSD Animal Health, Elanco Animal Health, Bayer AG, Indian Immunologicals Limited, and others.

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

Positron Emission Tomography Devices (PET) Market Trends| global Analysis - MRFR

 

Market Highlights

The global positron emission tomography devices (PET) market is expected to grow at an approximate CAGR of 5.6% during forecast period, 2018–2023.

Increasing cases of head and neck cancer is the key factor driving the positron emission tomography devices (PET) market. According to the 2018 data suggested by the Australian Institute of Health and Welfare, around 5,091 new cases of head and neck cancer were diagnosed and around 1,034 number of deaths occurred from head and neck cancer in Australia.

Various other factors such as increasing cases of cancer, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of positron emission tomography scanning are also expected to propel the growth of the market.

However, stringent regulatory guidelines, cost associated with PET scan, and shorter half-life of radioisotopes can hamper the market growth over the forecast period.

Segmentation

The global positron emission tomography devices (PET) market is segmented based on product type, applications, end user and region.

The global market for positron emission tomography devices (PET), by product type is segmented into full ring PET scanners and partial ring PET scanners.

The market, by applications, is segmented into cardiology, neurology, oncology, orthopaedics, urology, gastroenterology, and others

Based on end user, positron emission tomography devices (PET) market is segmented into hospitals, clinics, diagnostic centres, and others.

Regional Analysis

The Americas dominated the global market for positron emission tomography devices (PET) owing to presence of major market players and increased prevalence of Alzheimer's dementia within the region. As per the data suggested by the Alzheimer's Association, an estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018.

Europe is expected to hold the second largest position in the global positron emission tomography devices (PET) market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as, growing cases of head and neck cancer, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the global positron emission tomography devices (PET) market due to the low per capita income, especially within the African region.

Key Players

Some of the key players in the global positron emission tomography devices (PET) market are Agfa Healthcare, Gamma Medica Inc., GE Healthcare, Neusoft Medical Systems, Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens AG, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc. MedX Holdings Inc., Modus Medical Devices Inc., Radiology Oncology Systems, Inc., Yangzhou Kindsway Biotech Co. Ltd., Toshiba Corporation, Hitachi, Ltd., and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/positron-emission-tomography-devices-market-7254

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

News - Global Neonatal Thermoregulation Market Size, Demand, Analysis and Forecast

 

Market Highlights:

 

It is estimated that the Global Neonatal Thermoregulation Market is expected to hold a market value of USD 500 million and register a CAGR ~ 5.0 % during the forecast period of 2018–2023. Thermoregulation is the ability to create equilibrium between heat production and heat loss in order to maintain body temperature within a certain normal range. The provision of a thermoneutral environment is an essential component of the immediate and long-term care of newborn infants. With the surge in the birth rates of newborns, the equipment used for blood sampling and monitoring the baby is steadily increasing. According to a data published by the Centers for Disease Control and Prevention in January 2017, there were 3,945,875 births in the US in 2017. This means birth rate in US in 2017 was 12.2 per 1000 population. Moreover, rising prevalence of diseases in neonates fuels the growth of the market. However, stringent government regulation for product approval and possible side-effects for the neonates may hamper the market growth during the assessment period.

 

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6913

 

The global neonatal thermoregulation market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in November 2016, Drägerwerk AG & Co. KGaA introduced IncuWarmer Babyleo TN500 which offers optimal thermoregulation in open care, closed care and transition to the premature baby.

 

Regional Analysis:

 

The Americas is anticipated to dominate the global neonatal thermoregulation market owing to a well-developed healthcare sector, and rising prevalence of diseases. The involvement of government in creating awareness about the neonatal diseases also fuels the growth of the market. For instance, US government has programs like Screening Quality Assurance Programs and Heritable Disorders Program at Health Resources and Service Administration (HRSA). Thus, such initiatives and programs by the government as well as non-government organizations support the market growth. Europe is expected to hold the second largest position in the global neonatal thermoregulation market. The market growth in this region is attributed to the availability of funds for research. Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, and continuously developing economies, According to a report published by the International Journal of Social and Developmental Concerns in October 2017, in Malaysia, growth of the public primary as well as secondary care facilities has decreased in the past few years and it has not kept pace with the rapid urbanization. Thus, such factors restraint the growth of the market in this region. On the other hand, the Middle East & Africa has the least share of the market.

 

Segmentation:

 

The Global Neonatal Thermoregulation Market has been segmented into product type, modality, end-user, and region.The market, on the basis of product type, has been segmented into warmer, neonatal incubators, and neonatal cooling systems.The market, based on warmer, has been further segmented into radiant warmers and wall mount warmer.

 

The market, by neonatal incubators, has been sub-segmented into intensive care incubator and transport incubator.The market, by modality, has been segmented into open and closed.The market, by end-user, has been segmented into hospitals, pediatric and neonatal intensive care units, nursing homes, and others.

 

Browse Complete Report @ https://www.marketresearchfuture.com/reports/neonatal-thermoregulation-market-6913

 

Key Players:

 

Some of the key players in the global neonatal thermoregulation market are Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Natus Medical Incorporated, Inspiration Healthcare Group plc., , Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, International Biomedical, Ltd., Atom Medical Corporation, Fanem Ltd, and Novos Medical Systems.

 

Contact:

 

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Microcarriers Market Revenue, Global Opportunities, Emerging Technologies, Future Prospects and Forecast 2023

 

Market Highlights:

 

The Global Microcarrier Market is anticipated to hold a market value of USD 1.18 billion with an estimated CAGR of 5.9% during the forecast period. A microcarrier is a support matrix allowing the growth of adherent cells. The microcarrier system provides high cell yields without having to resort to bulky equipment and tedious methodology. The rise in the use of microcarrier technology for various cell-based applications, coupled with the advantages of the microcarrier system such as its support for high yield of cells, facilitation of polarization and differentiation of cells, and lower risk of contamination are expected to drive the growth of the market during the forecast period. Moreover, the rapid growth of the biologics industry also fuels the growth of this market. On the other hand, strict regulatory framework, and limitation in production of high-density cell culture may hinder the growth of the market during the forecast period.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6911

The global microcarrier market is currently dominated by many market players. These players are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in March 2018, Danaher announced that it has entered into a definitive agreement to acquire Integrated DNA Technologies, a privately-held provider of high-value consumables for genomics applications in next generation sequencing, synthetic biology, molecular biology, gene editing and molecular diagnostics.

 

Regional Analysis:

The market in the Americas is expected to dominate the global Microcarrier market during the forecast period owing to the increasing incidence of cancer and other chronic diseases, a well-developed healthcare sector and growing number of venture capital investments. According to data published by Centers for Disease Control and Prevention (CDC), 1,633,390 new cases of cancer were reported in the year 2015, and 595,919 people died of cancer in the United States in the same year. The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with the strategic expansion of biopharmaceutical companies in this region. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing disposable income and rising demand for cell-based vaccines. The market in the Middle East and Africa is likely to account for the smallest share of the global microcarrier market. The market growth in this region can be attributed to the growing government initiatives.

 

Segmentation:

The global microcarriers market has been segmented into product type, application, and end-user.The market, on the basis of type, has been segmented into equipment, and consumables.The market, based on equipment, has been segmented into bioreactors, culture vessels, cell counters, filtration systems, and other equipment.The market, based on consumables, has been sub-segmented into media, reagents, and microcarrier beads.The market, based on media, has been further segmented into serum-based media, serum-free media, and other media.

The market, based on microcarrier beads, has been sub-segmented into cationic microcarriers, collagen-coated microcarriers, protein-coated microcarriers, and other microcarrier beads.The market, on the basis of application, has been further segmented into vaccine manufacturing, cell therapy, biologics manufacturing, and other applications.The market, on the basis of end-user, has been further segmented into pharmaceutical and biotechnology companies, research institutes, and contract research organizations.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/microcarriers-market-6911

Key Players

Some of the key players in the global microcarrier market are Thermo Fisher Scientific Inc., Lonza, GENERAL ELECTRIC COMPANY, Corning Incorporated, Sartorius AG, Danaher, Merck KGaA, Becton, Dickinson and Company, Eppendorf AG and HiMedia Laboratories.

 

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com  .